4月5日，西维斯健康(CVS)盘中下跌5.07%，截至01:14，报64.09美元/股，成交3.84亿美元，总市值808.04亿美元。
财务数据显示，截至2024年12月31日，西维斯健康收入总额3728.09亿美元，同比增长4.2%；归母净利润46.14亿美元，同比减少44.7%。
大事提醒：
5月7日，西维斯健康将披露2025财年一季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。
资料显示，西维斯健康公司及其子公司是美国最大的药品零售商,该公司致力于通过医药创新,帮助人们改善健康。在不断变化的医疗保健领域最前沿,该公司拥有无与伦比的能力和推动创新所需的专业知识,在未来的医疗保健行业占有重要地位。为了满足所有顾客的健康需求,该公司在它的CVS药店体系中建立起多种创新的运营方法,包括它的网上药店CVS.com和专用药品分支机构PharmaCare。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.